A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS

Human Molecular Genetics
Seiichi NaganoToshiyuki Araki

Abstract

We previously showed by in vitro experiments that the cysteine residue (Cys111) near the dimer interface is critical for monomerization and resultant aggregate formation of mutant Cu, Zn-superoxide dismutase (SOD1) protein, which is toxic to motor neurons in familial amyotrophic lateral sclerosis (ALS). To verify the importance of Cys111 in the mutant SOD1-associated ALS pathogenesis in vivo, we analyzed the disease phenotype of SOD1 transgenic mice harboring H46R mutation alone (H46R mice) or H46R/C111S double mutations (H46R/C111S mice). Behavioral, histological and biochemical analyses of the spinal cord showed that the onset and progression of the disease phenotype were delayed in H46R/C111S mice compared with H46R mice. We found that peroxidized Cys111 of H46R SOD1 plays a role in promoting formation of high molecular weight insoluble SOD1 species that is correlated with the progression of the motor neuron disease phenotype. These results support that Cys111 is a critical residue for the neuronal toxicity of mutant SOD1 in vivo, and the blockage of peroxidation of this residue in mutant SOD1 may constitute a future target for developing ALS treatment.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H E PargeJ A Tainer
Oct 1, 1990·Laboratory Animals·J YamateS Sannai
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C J EpsteinY Groner
Nov 1, 1971·Analytical Biochemistry·C Beauchamp, I Fridovich
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y TakagiJ Yodoi
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·J A JohnstonR R Kopito
Nov 30, 2002·The Journal of Biological Chemistry·Ashutosh Tiwari, Lawrence J Hayward
Sep 10, 2003·Journal of Molecular Biology·Michael DiDonatoJohn A Tainer
Nov 4, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mikael J LindbergMikael Oliveberg
Jun 15, 2005·Annual Review of Biochemistry·Joan Selverstone ValentineSoshanna Zittin Potter
Jun 17, 2005·The Journal of Biological Chemistry·Ashutosh TiwariLawrence J Hayward
Dec 7, 2005·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yoshiaki FurukawaThomas V O'Halloran
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Han-Xiang DengTeepu Siddique
Jun 3, 2006·Science·Séverine BoilléeDon W Cleveland
Feb 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Makoto UrushitaniJean-Pierre Julien
Jun 6, 2007·Journal of Neuropathology and Experimental Neurology·Shoichi SasakiMakoto Iwata
Jun 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Lucia BanciJulian P Whitelegge
Aug 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Per ZetterströmStefan L Marklund
Oct 5, 2007·The Journal of Biological Chemistry·Noriko FujiwaraKeiichiro Suzuki
Feb 5, 2008·Nature Neuroscience·Koji YamanakaDon W Cleveland
Mar 11, 2009·Antioxidants & Redox Signaling·Madhuri Chattopadhyay, Joan Selverstone Valentine
Mar 21, 2009·The Journal of Biological Chemistry·Kyle C WilcoxNikolay V Dokholyan
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Celeste M KarchDavid R Borchelt
Jan 19, 2010·Free Radical Biology & Medicine·Hitoshi KishigamiSaburo Sakoda
Jul 12, 2011·Biochemistry·Rachel L RedlerNikolay V Dokholyan
Mar 21, 2012·Proceedings of the National Academy of Sciences of the United States of America·Terrell E BrothertonJonathan D Glass
Jul 19, 2013·The Journal of Biological Chemistry·Mauro Lo Conte, Kate S Carroll
Jan 1, 2012·Longevity & Healthspan·Lisa C FloresYuji Ikeno
Aug 7, 2014·The Journal of Biological Chemistry·Carles SolsonaJorge Alegre-Cebollada

❮ Previous
Next ❯

Citations

Jun 5, 2016·The Journal of Biological Chemistry·Cristina Álvarez-ZaldiernasArne Holmgren
Apr 11, 2018·Antioxidants & Redox Signaling·Juan I SbodioBindu D Paul
Aug 24, 2020·Redox Biology·Nachiyappan VenkatachalamStanislav Engel
Dec 22, 2019·Free Radical Biology & Medicine·Itsuki AnzaiYoshiaki Furukawa
Oct 30, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sofía IbarburuEmiliano Trias

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.